Enobia Pharma Alternatives & Competitors
12 companies similar to Enobia Pharma
Companies similar to Enobia Pharma
HemoShear Therapeutics
Developing new treatments for rare metabolic disorders
Charlottesville, United S...
Alcyone Lifesciences
Empowering Precision Therapies for Rare Neurological Disorders
StrideBio, Inc
The next evolution in gene therapy
Durham, United States
Track all Enobia Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Travere Therapeutics
In rare for life.
San Diego, United States
Acceleron Pharma
Accelerating drug discovery to transform patients' lives
Cambridge, United States
Sierra Oncology
We are on a mission to deliver transformative therapies that treat rare forms of cancer.
San Mateo, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Hopewell Therapeutics, Inc.
Enabling a new generation of genomic medicines for patients with high unmet medical needs.
Woburn, United States
Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
San Diego, United States
Xenon Pharmaceuticals Inc.
A neuroscience-focused biopharmaceutical company
Canada
Biocon
Transforming Healthcare. Transforming Lives.
Bengaluru, India
About Enobia Pharma
Enobia Pharma is a Canadian biotechnology company founded in 1997, dedicated to developing therapies for serious genetic bone disorders with no approved treatments. Their lead product, ENB-0040, is a subcutaneous bone-targeted enzyme replacement therapy designed for the rare disease hyposphostasia. The company speciali...
Enobia, Genetic Bone Disorders, Therapies, ENB-0040, Enzyme Replacement Therapy, Hyposphosphatasia, Subcutaneous, Rare Disease, Tissue Non-specific Alkaline Phosphatase, Drug Development, Biopharmaceuticals
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Enobia Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Enobia Pharma on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
